Abstract
Backgrounds and aims
Although a number of studies have been conducted on the association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and diabetic nephropathy (DN) in Chinese population, this association remains elusive and controversial. To further assess the effects of PAI-1 4G/5G polymorphism on the risk of DN, a meta-analysis was performed in the Chinese population.
Methods
Relevant studies were identified using PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure, and Chinese Biology Medicine through November, 2015. Pooled odds ratios (ORs) and 95 % confidence intervals (CIs) were used to assess the strength of the associations.
Results
This meta-analysis identified nine studies, including 777 DN cases, 413 healthy controls, and 523 DM controls. In the total analyses, a significantly elevated risk of DN was associated with variants of PAI-1 4G/5G when compared with the healthy group (4G vs. 5G, OR 2.46, 95 % CI 1.45–4.16; 4G/4G vs. 5G/5G, OR 4.32, 95 % CI 1.79–10.39; 4G/4G vs. 4G/5G +5G/5G, OR 2.96, 95 % CI 1.59–5.53; 4G/4G +4G/5G vs. 5G/5G, OR 2.78, 95 % CI 1.34–5.75) and DM group (4G vs. 5G, OR 1.93, 95 % CI 1.28–2.92; 4G/4G vs. 5G/5G, OR 2.99, 95 % CI 1.44–6.21; 4G/4G vs. 4G/5G +5G/5G, OR 2.84, 95 % CI 1.77–4.54). In the subgroup analyses stratified by ethnicity and geographic areas, it revealed the significant results in Chinese Han, in North and South China.
Conclusions
This meta-analysis showed that the PAI-1 4G/4G variant, 4G allele might be risk alleles for DN susceptibility in the Chinese population, and further studies in other ethic groups are required for definite conclusions.
Similar content being viewed by others
References
Wang S, Mitu GM, Hirschberg R (2008) Osmotic polyuria: an overlooked mechanism in diabetic nephropathy. Nephrol Dial Transplant 23(7):2167–2172
Jawa A, Kcomt J, Fonseca VA (2004) Diabetic nephropathy and retinopathy. Med Clin N Am 88(4):1001–1036
Wan Q, Xu Y, Dong E (2015) Diabetic nephropathy research in China: data analysis and review from National Natural Science Foundation of China. J Diabetes 7(3):307–314
Yang W, Lu J, Weng J et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101
Mooyaart AL (2014) Genetic associations in diabetic nephropathy. Clin Exp Nephrol 18(2):197–200
Kimura H, Gejyo F, Suzuki Y et al (1998) Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1. Kidney Int 4(5):1659–1669
Liu SQ (2004) Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and Guangdong Hanzu type 2 diabetic nephropathy patients. Master thesis of Southern Medical University, China (article in Chinese)
Liu MY (2007) Association of plasminogen activator inhibitor-1 4G/5G polymorphism and type 2 diabetes with early nephropathy. Master thesis of Qingdao University, China (article in Chinese)
Yan XF (2003) Polymorphisms of angiotensin I converting enzyme and plasminogen activator inhibitor-1 genes in type 2 diabetes with nephropathy. Master thesis of Fujian Medical University, China (article in Chinese)
Li CG, Yang NL (2002) Polymorphisms of eNOS intron 4 and plasminogen activator inhibitor-1 genes in diabetic nephropathy. Shandong Med J 42:16–18 (article in Chinese)
Wang L (2004) The relationship between polymorphisms of PAI-1 gene, PAI-1 antigen in plasma with diabetes nephropathy. Master thesis of Jilin University, China (article in Chinese)
Tang KX (2004) Correlation between PAI-1 gene expression, insulin resistance and vascular disease in obese T2DM adipose tissue. Doctor thesis of Shandong University, China (article in Chinese)
Wong TY, Poon P, Szeto CC, Chan JC, Li PK (2000) Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int 57(2):632–638
Li CG, Dong YH, Wang HY et al (2001) Association o f plasminogen activator inhibitor-1 4G/4G polymorphism and type 2 diabetic nephropathy. Chin J Diabetes 9(333–336):340 (article in Chinese)
Liu SQ, Xue YM, Yang GC, He FY, Zhao XS (2004) Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province. Di Yi Jun Yi Da Xue Xue Bao 24(8):904–907 (article in Chinese)
Tang KX (2004) The association between gene expression of PAl-1 in adipose tissue of type 2 diabetes and vascular disease. J Shangdong Univ (Med Sci) 15(6):1126–1128 (article in Chinese)
Wang L, Liu Y, Guo H (2007) Correlation analysis of plasminogen activator inhibitor-1 gene polymorphism, antigen content and nephropathy in type 2 diabetes. Chin J Gerontol 27:1485–1487 (article in Chinese)
Zheng TS, Liu LM, Zhou WR et al (2007) Correlation of plasminogen activator inhibitor-1 gene polymorphism with type 2 diabetic nephropathy in Chinese. J Shanghai Jiaotong Univ (Med Sci) 27(7):774–776 (article in Chinese)
Yan XF, Pan SZ, Yang LY, Huang LN, Zhao SH (2008) Correlation analysis of polymorphisms of angiotensin converting enzyme gene, plasminogen activator inhibitor-1 gene and nephropathy in type 2 diabetes. China Med 3:81–83 (article in Chinese)
Xue J, Tian GS, Shi FH, Ge B (2010) Polymorphisms of plasminogen activator inhibitor-I genes in type 2 diabetes with nephropathy in Han in Baotou. Chin Med J Metall Ind 27:373–375 (article in Chinese)
Liu MY, Yang ZS, Shen LY, Sun SY, Li H (2011) Association of plasminogen activator inhibitor-1 4G/5G polymorphism and type 2 diabetes with early nephropathy. Acta Acad Med Qingdao Univ 47(31–32):35 (article in Chinese)
Eid S, Abou-Kheir W, Sabra R et al (2013) Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. J Biol Regul Homeost Agents 27:693–703
Xue C, Nie W, Zhou C et al (2014) 4G/4G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy. Ren Fail 36(3):332–338
Xu K, Liu X, Yang F et al (2013) PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study. PLoS One 8(11):e79150
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The results presented in this paper have not been published previously. None of the authors have any conflicts of interests to declare.
Ethical standard
This is a meta-analysis, so ethical approval is not concerned.
Rights and permissions
About this article
Cite this article
Gao, Wf., Guo, Yb., Bai, Y. et al. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population. Int Urol Nephrol 48, 1483–1489 (2016). https://doi.org/10.1007/s11255-016-1333-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-016-1333-9